Birchtech Corp. develops specialty activated carbon technologies for air and water treatment. Company news centers on SEA® sorbent technologies for mercury emissions capture in the coal-fired utility sector, water purification applications for PFAS and other contaminants, and product expansion into SEA-IX™ nuclear-grade ion exchange resins and granular activated carbon solutions.
Recurring updates also cover quarterly financial results, licensing and intellectual property developments, public-company governance changes, and industry presentations tied to municipal water, industrial wastewater, nuclear power, and utility markets.
Birchtech (NYSE American:BCHT) reported first quarter 2026 revenue of $4.2 million, up 32% year-over-year, with gross profit of $1.4 million and net loss narrowing to $1.3 million ($0.06/share). Cash rose to $14.7 million with no debt after a $16.4 million equity raise.
The company launched its SEA-IX™ nuclear-grade ion exchange resin line, secured about $1 million in initial orders, began collection efforts on a $78 million final patent judgment, uplisted to NYSE American, expanded water-treatment collaborations, and appointed a new CFO.
Birchtech (NYSE American: BCHT) appointed Michael Mioska, CPA, MBA, as Chief Financial Officer, effective May 5, 2026.
Mioska brings over 20 years of accounting, audit and financial reporting experience, has served as an independent consultant since 2021 and advised Birchtech since 2023, providing familiarity aimed at a seamless transition.
Birchtech (NYSE American: BCHT) will release its first quarter 2026 financial results after market close on May 13, 2026 and will host an investor conference call at 5:00 p.m. Eastern that day.
Dial-in numbers, conference ID 13760298, webcast link, replay details through June 3, 2026, and one-year webcast availability are provided for participants.
Birchtech (NYSE American: BCHT) will exhibit at four water industry conferences in May–June 2026, showcasing water treatment solutions including Design Center Analytical Services, SEA-IX™ nuclear-grade ion exchange resins, and granular activated carbon (GAC) for PFAS removal.
Dr. Nicholas Lentz will deliver a featured presentation on PFAS removal using RSSCTs at the AWWA technical conference, May 4-6, 2026 in State College, Pennsylvania (Booth #57). For meetings contact sales@birchtech.com; more information at www.birchtech.com.
Birchtech (NYSE American: BCHT) reported Q4 2025 results and corporate milestones on March 31, 2026. Product revenues rose 19.8% YoY while total Q4 revenue fell to $3.8M. The company obtained a $78M final judgment, completed an NYSE American uplisting and raised $16.6M.
Management highlighted commercialization progress in water solutions, launch of SEA-IX™, $0.9M in utility purchase orders, and plans to collect the judgment and scale Carbon Rejuvenation™.
Birchtech (NYSE American: BCHT) launched the SEA-IX™ nuclear-grade ion exchange resin line, targeting an estimated $185–$255 million annual addressable market across nuclear, coal-fired utilities, and municipal water treatment.
The U.S.-distributed line offers 11 formulations, shorter lead times, and has $1.0 million purchase orders to-date (including $0.4 million in March 2026); initial customer results show improved throughput and reduced material usage.
Birchtech (NYSE American: BCHT) will release fourth quarter 2025 financial results after market close on Tuesday, March 31, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time the same day to discuss results and provide a corporate update.
Dial-in numbers, conference ID 13759505, webcast link, telephone playback through April 21, 2026, and a one-year webcast replay are provided for investors.
Birchtech (NYSE American: BCHT) management will participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026. President and CEO Richard MacPherson will give a webcast presentation and hold one-on-one investor meetings on March 10, 2026 at 12:30 p.m. ET.
A live audio webcast and archived replay will be available via the conference webcast link; registration is required to attend and meetings can be scheduled through MZ Group at the provided contact email.
Birchtech (NYSE American: BCHT) issued a shareholder letter outlining 2025 progress and 2026 priorities. Key points: $78 million federal court judgment, ~$37 million in license fees and settlements since 2020, a $15 million capital raise concurrent with an NYSE American listing, early water-market wins including ~$0.9 million in purchase orders, and plans to build a granular activated carbon rejuvenation facility targeting late 2027.
The company highlights expanding licensing, scaling water treatment pilots, and a strategy to grow recurring supply-and-service revenue.
Birchtech (NYSE American: BCHT) priced an underwritten public offering of 6,250,000 common shares at $2.40 per share for aggregate gross proceeds of approximately $15.0 million. The company granted a 30-day option for an additional 937,500 shares to cover over-allotments.
Proceeds will be used for continuing operating expenses, working capital and general corporate purposes. Birchtech’s common stock will begin trading on the NYSE American on or about February 26, 2026, and OTCQB trading will terminate; the TSX listing will remain.